13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001922318
Total reported value
$1.4B
$1.4B
54 檔
36.0%
According to the latest 13F quarterly dataset, Pale Fire Capital SE managed an equity portfolio of $1.4B at the end of Q3 2024, spanning 54 distinct U.S. exchange-listed positions.
During Q3 2024, Pale Fire Capital SE's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | T | At&t Inc | Stock-Comm Services | 33.13% | +1.67% | NEW | |
| 2 | DOLE | Dole plc | Stock-Other | 16.73% | -2.69% | -20.12% | |
| 3 | GRPN | Groupon Inc | Stock-Other | 15.61% | +6.67% | — | |
| 4 | BTG | B2gold CORP | Stock-Other | 8.30% | -10.69% | -11.08% | |
| 5 | INSW | International Seaways, Inc. | Stock-Other | 6.10% | — | -21.20% | |
| 6 | TDOC | Teladoc Health Inc | Stock-Healthcare | 2.95% | -0.45% | +91.87% | |
| 7 | CGAU | Centerra Gold Inc | Stock-Other | 2.49% | — | -22.24% | |
| 8 | ANGI1EUR | Angi Inc | Stock-Other | 2.18% | — | -15.86% | |
| 9 | TEN | Tsakos Energy Navigation Limited | Stock-Other | 1.99% | — | -0.55% | |
| 10 | IAUX | I-80 Gold CORP | Stock-Other | 1.80% | -0.86% | +2378.28% | |
| 11 | NMM | Navios Maritime Partners L.P. | Stock-Other | 1.67% | — | -75.31% | |
| 12 | CIM | Chimera Investment CORP | Stock-Other | 0.84% | — | — | |
| 13 | PRAX | Praxis Precision Medicines I | Stock-Other | 0.61% | — | — | |
| 14 | OCUL | Ocular Therapeutix Inc | Stock-Other | 0.60% | — | — | |
| 15 | SSTK | Shutterstock Inc | Stock-Other | 0.53% | — | — | |
| 16 | STNG | Scorpio Tankers Inc. | Stock-Other | 0.51% | — | -87.36% | |
| 17 | ORANY | Orange-spon Adr | Stock-Other | 0.45% | — | — | |
| 18 | SHEL | Shell Plc-adr | Stock-Energy | 0.42% | — | -98.15% | |
| 19 | AVU0 | Adverum Biotechnologies Inc | Stock-Other | 0.34% | — | — | |
| 20 | DHC | Diversified Healthcare Trust | Stock-Other | 0.29% | — | -31.14% | |
| 21 | QURE | uniQure N.V. | Stock-Other | 0.26% | — | +412.91% | |
| 22 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 0.26% | +0.30% | +292.39% | |
| 23 | CRBU | Caribou Biosciences Inc | Stock-Other | 0.23% | — | +1779.21% | |
| 24 | ADAM | Adamas Trust Inc | Stock-Other | 0.21% | — | — | |
| 25 | ✓ | Despegar.com CORP | Stock-Other | 0.19% | — | — | |
| 26 | ASNSUSD | X4 Pharmaceuticals Inc | Stock-Other | 0.17% | — | +805.37% | |
| 27 | ✓ | Rapt Therapeutics Inc | Stock-Other | 0.16% | — | +3078.12% | |
| 28 | MITT | Tpg Mortgage Investment Trus | Stock-Other | 0.16% | — | — | |
| 29 | ✓ | Inozyme Pharma Inc | Stock-Other | 0.15% | — | +384.66% | |
| 30 | RNW | ReNew Energy Global Plc | Stock-Other | 0.06% | — | +236.47% | |
| 31 | IOVA | Iovance Biotherapeutics Inc | Stock-Other | 0.06% | — | +154.25% | |
| 32 | IRON | Disc Medicine Inc | Stock-Other | 0.05% | — | — | |
| 33 | ✓ | Immatics NV | Stock-Other | 0.04% | -0.01% | EXIT | |
| 34 | BHVN | Biohaven Ltd. | Stock-Other | 0.04% | — | — | |
| 35 | CELC | Celcuity Inc | Stock-Other | 0.04% | — | +49.82% | |
| 36 | ✓ | Stock-Other | 0.04% | — | +11.69% | ||
| 37 | CMRXEUR | Chimerix Inc | Stock-Other | 0.04% | — | +53.40% | |
| 38 | BDTX | Black Diamond Therapeutics I | Stock-Other | 0.04% | — | +35.86% | |
| 39 | ✓ | Verve Therapeutics Inc | Stock-Other | 0.03% | — | — | |
| 40 | TCRX | Tscan Therapeutics Inc | Stock-Other | 0.03% | — | +102.67% | |
| 41 | LRMR | Larimar Therapeutics Inc | Stock-Other | 0.03% | +0.01% | NEW | |
| 42 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 0.03% | — | — | |
| 43 | ACHV | Achieve Life Sciences Inc | Stock-Other | 0.02% | — | — | |
| 44 | AQST | Aquestive Therapeutics Inc | Stock-Other | 0.02% | — | — | |
| 45 | RZLT | Rezolute Inc | Stock-Other | 0.02% | — | — | |
| 46 | SYRS | Syros Pharmaceuticals Inc | Stock-Other | 0.02% | — | — | |
| 47 | CMPX | Compass Therapeutics Inc | Stock-Other | 0.01% | — | -63.15% | |
| 48 | CLRBUSD | Cellectar Biosciences Inc | Stock-Other | 0.01% | — | — | |
| 49 | ODV | Osisko Development CORP | Stock-Other | 0.01% | — | -30.72% | |
| 50 | BWEN | Broadwind Inc | Stock-Other | 0.01% | — | — |
According to official SEC Form 13F filings, Pale Fire Capital SE reported a total U.S. public equity portfolio value of $1.4B across 54 disclosed positions in Q3 2024.
During Q3 2024, Pale Fire Capital SE's top holdings by market value included T (33.1%)、DOLE (16.7%)、GRPN (15.6%). The largest single position, T, represented 33.1% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including T, DOLE, GRPN) accounted for 36.0% of total reported equity market value during Q3 2024.
In Q3 2024, Pale Fire Capital SE made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.